Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years-Reference-Cited by-同舟云学术

Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years

Published:2019-12 Issue:12 Volume:106 Page:1086-1093
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:en
Short-container-title:Bulletin du Cancer

Author:

Chanal Edouard,Bouleftour Wafa,Guillot Aline,Rowinski Elise,Bernichon Emilie,Tremeau Lancelot,Lardon Renaud,Lacroix Bertrand,Lorin Stephane,Delorme Gregory,Perraud Yves,Armand Corinne,Levigne Frederic,Vallard Alexis,Langrand-Escure Julien,Fournel Pierre,Benoite Mery,Vassal Cecile

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference30 articles.

1. Advances in the treatment of testicular cancer;Ehrlich;Transl Androl Urol,2015

2. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing;Ruf;Urol Oncol,2014

3. Management of stage I testis cancer;Albers;Eur Urol,2007

4. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis;Warde;J Clin Oncol,2002

5. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial;Albers;J Clin Oncol,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active Surveillance beim Hodenkarzinom;Uro-News;2023-07

2. Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review;World Journal of Urology;2022-09-15